Gemma Domínguez Muñoz-rekin lankidetzan egindako argitalpenak (13)

2022

  1. In-depth proteomics characterization of ∆Np73 effectors identifies key proteins with diagnostic potential implicated in lymphangiogenesis, vasculogenesis and metastasis in colorectal cancer

    Molecular Oncology, Vol. 16, Núm. 14, pp. 2672-2692

2021

  1. Multiplexed Biosensing Diagnostic Platforms Detecting Autoantibodies to Tumor-Associated Antigens from Exosomes Released by CRC Cells and Tissue Samples Showed High Diagnostic Ability for Colorectal Cancer

    Engineering, Vol. 7, Núm. 10, pp. 1393-1412

  2. ∆Np73, TAp73 and ∆133p53 Extracellular Vesicle Cargo as Early Diagnosis Markers in Colorectal Cancer

    Cancers, Vol. 13, Núm. 9

2020

  1. Identification of tumor-associated antigens with diagnostic ability of colorectal cancer by in-depth immunomic and seroproteomic analysis

    Journal of Proteomics, Vol. 214

  2. Multiplexed monitoring of a novel autoantibody diagnostic signature of colorectal cancer using HaloTag technology-based electrochemical immunosensing platform

    Theranostics, Vol. 10, Núm. 7, pp. 3022-3034

2019

  1. Disposable Amperometric Immunosensor for the Determination of the E-Cadherin Tumor Suppressor Protein in Cancer Cells and Human Tissues

    Electroanalysis, Vol. 31, Núm. 2, pp. 309-317

  2. The specific seroreactivity to ∆Np73 isoforms shows higher diagnostic ability in colorectal cancer patients than the canonical p73 protein

    Scientific reports, Vol. 9, Núm. 1, pp. 13547

  3. ΔNp73 and Δ133p53 in liquid biopsy as early diagnostic markers for colorectal cancer

    Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 30, pp. iv86-iv87

2018

  1. Clinical implications of the deregulated TP73 isoforms expression in cancer

    Clinical and Translational Oncology, Vol. 20, Núm. 7, pp. 827-836

  2. Determination of Cadherin-17 in Tumor Tissues of Different Metastatic Grade Using a Single Incubation-Step Amperometric Immunosensor

    Analytical Chemistry, Vol. 90, Núm. 18, pp. 11161-11167

2017

  1. Clinical relevance of colorectal cancer molecular subtypes

    Critical Reviews in Oncology/Hematology, Vol. 109, pp. 9-19

2016

  1. Toward liquid biopsy: Determination of the humoral immune response in cancer patients using halotag fusion protein-modified electrochemical bioplatforms

    Analytical Chemistry, Vol. 88, Núm. 24, pp. 12339-12345

2009

  1. SNAI1 expression in colon cancer related with CDH1 and VDR downregulation in normal adjacent tissue

    Oncogene, Vol. 28, Núm. 49, pp. 4375-4385